Crohn's Disease Clinical Trials in Milwaukee, Wisconsin

3 studies are recruiting for crohn's disease in Milwaukee, Wisconsin right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

    The main purpose of this study is to evaluate the efficacy and safety of mirikizumab and placebo compared with mirikizumab and concomitantly administered tirzepatide in adult participants with moderately to severely active CD and obesity, or overweight. The maximum duration of this study is up to 6…

    Stage
    Phase 3
    Ages
    18 to 70
    Site
    Wisconsin Center for Advanced Research, Milwaukee, Wisconsin
    Locations
    183 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06937099 on ClinicalTrials.gov

  2. A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

    The main aim of this study is to learn whether vedolizumab and upadacitinib given together (also called dual targeted therapy or DTT) reduces bowel inflammation and ulcers in the bowel compared to vedolizumab only (also called monotherapy) in adults with moderately or severely active Crohn's Diseas…

    Stage
    Phase 3
    Ages
    18 to 65
    Site
    Medical College of Wisconsin Cancer Center - Froedtert Hospital, Milwaukee, Wisconsin
    Locations
    138 in total
    Run by
    Takeda

    See if you can join NCT06227910 on ClinicalTrials.gov

  3. A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

    This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Mirador Therapeutics Selected Site, Milwaukee, Wisconsin
    Locations
    66 in total
    Run by
    Mirador Therapeutics, Inc.

    See if you can join NCT07113522 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.